ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Aten Therapeutics Ltd

Aten Therapeutics Ltd is an active company incorporated on 7 October 2016 with the registered office located in Edinburgh, City of Edinburgh. Aten Therapeutics Ltd was registered 8 years ago.
Status
Active
Active since 3 years ago
Company No
SC547221
Private limited company
Scottish Company
Age
8 years
Incorporated 7 October 2016
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 16 October 2024 (10 months ago)
Next confirmation dated 16 October 2025
Due by 30 October 2025 (1 month remaining)
Last change occurred 3 years ago
Accounts
Submitted
For period 1 Oct30 Sep 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 30 September 2025
Due by 30 June 2026 (9 months remaining)
Contact
Address
1 Lochrin Square
92-98 Fountainbridge
Edinburgh
EH3 9QA
Scotland
Same address for the past 5 years
Telephone
0131 3574251
Email
Unreported
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in England • Born in Apr 1967
Director • Ceo • Scottish • Lives in Scotland • Born in Jun 1961
Oncobiopharm Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Oncobiopharm Limited
Wilfred Sydney Hanna and Mr Ian Abercrombie are mutual people.
Active
Medannex Limited
Wilfred Sydney Hanna and Mr Ian Abercrombie are mutual people.
Active
Thirty Holdings Limited
Wilfred Sydney Hanna is a mutual person.
Active
Thirty Respiratory Limited
Wilfred Sydney Hanna is a mutual person.
Active
Thirty Therapeutics Limited
Wilfred Sydney Hanna is a mutual person.
Active
Edixomed Limited
Wilfred Sydney Hanna is a mutual person.
Active
Thirty Animal Health Limited
Wilfred Sydney Hanna is a mutual person.
Dissolved
Thirty Pharma Limited
Wilfred Sydney Hanna is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
30 Sep 2024
For period 30 Sep30 Sep 2024
Traded for 12 months
Cash in Bank
£433
Decreased by £26.94K (-98%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£5.32K
Decreased by £29.09K (-85%)
Total Liabilities
-£133.78K
Decreased by £46.28K (-26%)
Net Assets
-£128.46K
Increased by £17.19K (-12%)
Debt Ratio (%)
2515%
Increased by 1991.42% (+381%)
Latest Activity
Full Accounts Submitted
2 Months Ago on 23 Jun 2025
Confirmation Submitted
9 Months Ago on 28 Nov 2024
Full Accounts Submitted
1 Year 2 Months Ago on 25 Jun 2024
Confirmation Submitted
1 Year 10 Months Ago on 18 Oct 2023
Small Accounts Submitted
2 Years 2 Months Ago on 30 Jun 2023
Confirmation Submitted
2 Years 10 Months Ago on 17 Oct 2022
Accounting Period Shortened
3 Years Ago on 3 Aug 2022
Dormant Accounts Submitted
3 Years Ago on 27 Jul 2022
Mr Ian Abercrombie Appointed
3 Years Ago on 2 Feb 2022
Confirmation Submitted
3 Years Ago on 26 Oct 2021
Get Credit Report
Discover Aten Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 30 September 2024
Submitted on 23 Jun 2025
Confirmation statement made on 16 October 2024 with no updates
Submitted on 28 Nov 2024
Total exemption full accounts made up to 30 September 2023
Submitted on 25 Jun 2024
Confirmation statement made on 16 October 2023 with no updates
Submitted on 18 Oct 2023
Accounts for a small company made up to 30 September 2022
Submitted on 30 Jun 2023
Confirmation statement made on 16 October 2022 with no updates
Submitted on 17 Oct 2022
Current accounting period shortened from 31 October 2022 to 30 September 2022
Submitted on 3 Aug 2022
Accounts for a dormant company made up to 31 October 2021
Submitted on 27 Jul 2022
Appointment of Mr Ian Abercrombie as a director on 2 February 2022
Submitted on 15 Feb 2022
Confirmation statement made on 16 October 2021 with updates
Submitted on 26 Oct 2021
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year